Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil

被引:26
作者
Arteaga, E [1 ]
Ianni, BM [1 ]
Fernandes, F [1 ]
Mady, C [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Cardiomyopathy Div, Heart Incor InCor, BR-05410020 Sao Paulo, Brazil
关键词
D O I
10.1016/j.ahj.2004.09.049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Selected patients with hypertrophic cardiomyopathy (HCM) have 3% to 4% annual mortality as compared to only 0.5% to 1.5% in nonselected patients. Our aim was to evaluate survival and prognostic factors in HCM in patients in a tertiary care center. Methods From 1980 to 1997, 214 patients were prospectively studied, with a mean follow-up of 7 years (range 1-25 years); there were 102 male and 112 female patients, aged 37 16 years (range 3-76 years). All patients had 12-lead electrocardiogram, 24-hour Halter monitor, and surface echocardiography. Univariate analysis was performed for known adverse factors such as young age, family history, syncope, functional class, atrial fibrillation, ventricular hypertrophy, left ventricular outflow tract obstruction, and nonsustained ventricular tachycardia. Results There were 22 deaths (10%), 15 directly related to HCM (sudden in 11). The cumulative survival rates were 94.5% at 5 years, 91% at 10 years, and 87.9% at 15 years. The annual mortality rate was 1%. Only New York Heart Association functional class III/IV and maximal ventricular wall thickness >30 mm were associated with HCM-related cardiac death. Conclusions We concluded that even a referred population of HCM patients may have a relatively benign outcome. Prognosis is related to advanced functional class and degree of left ventricular hypertrophy.
引用
收藏
页码:1099 / 1105
页数:7
相关论文
共 46 条
[1]  
AZZANO O, 1995, ARCH MAL COEUR VAISS, V88, P667
[2]  
BRAUNWALD E, 1964, CIRCULATION, V30, P3
[3]   NATURAL-HISTORY OF HYPERTROPHIC CARDIOMYOPATHY - A POPULATION-BASED STUDY, 1976 THROUGH 1990 [J].
CANNAN, CR ;
REEDER, GS ;
BAILEY, KR ;
MELTON, LJ ;
GERSH, BJ .
CIRCULATION, 1995, 92 (09) :2488-2495
[4]   HYPERTROPHIC CARDIOMYOPATHY IN TUSCANY - CLINICAL COURSE AND OUTCOME IN AN UNSELECTED REGIONAL POPULATION [J].
CECCHI, F ;
OLIVOTTO, I ;
MONTEREGGI, A ;
SANTORO, G ;
DOLARA, A ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (06) :1529-1536
[5]   Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy [J].
Elliott, PM ;
Blanes, JRG ;
Mahon, NG ;
Poloniecki, JD ;
McKenna, WJ .
LANCET, 2001, 357 (9254) :420-424
[6]   Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients [J].
Elliott, PM ;
Poloniecki, J ;
Dickie, S ;
Sharma, S ;
Monserrat, L ;
Varnava, A ;
Mahon, NG ;
McKenna, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2212-2218
[7]   PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY - PROSPECTIVE EVALUATION OF A THERAPEUTIC STRATEGY BASED ON CLINICAL, HOLTER, HEMODYNAMIC, AND ELECTROPHYSIOLOGICAL FINDINGS [J].
FANANAPAZIR, L ;
CHANG, AC ;
EPSTEIN, SE ;
MCAREAVEY, D .
CIRCULATION, 1992, 86 (03) :730-740
[8]   NATURAL-HISTORY OF HYPERTROPHIC CARDIOMYOPATHY IN THE ELDERLY [J].
FAY, WP ;
TALIERCIO, CP ;
ILSTRUP, DM ;
TAJIK, AJ ;
GERSH, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (04) :821-826
[9]   IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS - CLINICAL ANALYSIS OF 126 PATIENTS WITH EMPHASIS ON NATURAL HISTORY [J].
FRANK, S ;
BRAUNWALD, E .
CIRCULATION, 1968, 37 (05) :759-+
[10]   ABNORMAL-BLOOD PRESSURE RESPONSE DURING EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY [J].
FRENNEAUX, MP ;
COUNIHAN, PJ ;
CAFORIO, ALP ;
CHIKAMORI, T ;
MCKENNA, WJ .
CIRCULATION, 1990, 82 (06) :1995-2002